Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial

BACKGROUND: Laboratory testing is typically required for patients with atopic dermatitis (AD) treated with systemic immunosuppressants. A previous analysis of laboratory outcomes in randomized, double-blinded, placebo-controlled clinical trials of dupilumab in adults with moderate-to-severe AD found...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Clin Dermatol
Main Authors: Siegfried, Elaine C., Bieber, Thomas, Simpson, Eric L., Paller, Amy S., Beck, Lisa A., Boguniewicz, Mark, Schneider, Lynda C., Khokhar, Faisal A., Chen, Zhen, Prescilla, Randy, Mina-Osorio, Paola, Bansal, Ashish
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2021
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7973645/
https://ncbi.nlm.nih.gov/pubmed/33655423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40257-020-00583-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados